304 related articles for article (PubMed ID: 12354296)
1. Pyroglutamate-modified amyloid beta-peptides--AbetaN3(pE)--strongly affect cultured neuron and astrocyte survival.
Russo C; Violani E; Salis S; Venezia V; Dolcini V; Damonte G; Benatti U; D'Arrigo C; Patrone E; Carlo P; Schettini G
J Neurochem; 2002 Sep; 82(6):1480-9. PubMed ID: 12354296
[TBL] [Abstract][Full Text] [Related]
2. Immunodominant epitope and properties of pyroglutamate-modified Abeta-specific antibodies produced in rabbits.
Acero G; Manoutcharian K; Vasilevko V; Munguia ME; Govezensky T; Coronas G; Luz-Madrigal A; Cribbs DH; Gevorkian G
J Neuroimmunol; 2009 Aug; 213(1-2):39-46. PubMed ID: 19545911
[TBL] [Abstract][Full Text] [Related]
3. Identification of N-terminally truncated pyroglutamate amyloid-β in cholesterol-enriched diet-fed rabbit and AD brain.
Perez-Garmendia R; Hernandez-Zimbron LF; Morales MA; Luna-Muñoz J; Mena R; Nava-Catorce M; Acero G; Vasilevko V; Viramontes-Pintos A; Cribbs DH; Gevorkian G
J Alzheimers Dis; 2014; 39(2):441-55. PubMed ID: 24240639
[TBL] [Abstract][Full Text] [Related]
4. Novel monoclonal antibody 3B8 specifically recognizes pyroglutamate-modified amyloid β 3-42 peptide in brain of AD patients and 3xTg-AD transgenic mice.
Acero G; Garay C; Venegas D; Ortega E; Gevorkian G
Neurosci Lett; 2020 Apr; 724():134876. PubMed ID: 32114116
[TBL] [Abstract][Full Text] [Related]
5. Pyroglutamate-Modified Amyloid β (11- 40) Fibrils Are More Toxic than Wildtype Fibrils but Structurally Very Similar.
Scheidt HA; Adler J; Zeitschel U; Höfling C; Korn A; Krueger M; Roßner S; Huster D
Chemistry; 2017 Nov; 23(62):15834-15838. PubMed ID: 28857302
[TBL] [Abstract][Full Text] [Related]
6. Anti-11[E]-pyroglutamate-modified amyloid β antibodies cross-react with other pathological Aβ species: relevance for immunotherapy.
Perez-Garmendia R; Ibarra-Bracamontes V; Vasilevko V; Luna-Muñoz J; Mena R; Govezensky T; Acero G; Manoutcharian K; Cribbs DH; Gevorkian G
J Neuroimmunol; 2010 Dec; 229(1-2):248-55. PubMed ID: 20864186
[TBL] [Abstract][Full Text] [Related]
7. Toxicity of pyroglutaminated amyloid beta-peptides 3(pE)-40 and -42 is similar to that of A beta1-40 and -42.
Tekirian TL; Yang AY; Glabe C; Geddes JW
J Neurochem; 1999 Oct; 73(4):1584-9. PubMed ID: 10501204
[TBL] [Abstract][Full Text] [Related]
8. N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits.
Tekirian TL; Saido TC; Markesbery WR; Russell MJ; Wekstein DR; Patel E; Geddes JW
J Neuropathol Exp Neurol; 1998 Jan; 57(1):76-94. PubMed ID: 9600199
[TBL] [Abstract][Full Text] [Related]
9. Astrocytes and microglia but not neurons preferentially generate N-terminally truncated Aβ peptides.
Oberstein TJ; Spitzer P; Klafki HW; Linning P; Neff F; Knölker HJ; Lewczuk P; Wiltfang J; Kornhuber J; Maler JM
Neurobiol Dis; 2015 Jan; 73():24-35. PubMed ID: 25204716
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-β Peptide Aβ3pE-42 Induces Lipid Peroxidation, Membrane Permeabilization, and Calcium Influx in Neurons.
Gunn AP; Wong BX; Johanssen T; Griffith JC; Masters CL; Bush AI; Barnham KJ; Duce JA; Cherny RA
J Biol Chem; 2016 Mar; 291(12):6134-45. PubMed ID: 26697885
[TBL] [Abstract][Full Text] [Related]
11. Purification and Characterization of Recombinant N-Terminally Pyroglutamate-Modified Amyloid-β Variants and Structural Analysis by Solution NMR Spectroscopy.
Dammers C; Gremer L; Neudecker P; Demuth HU; Schwarten M; Willbold D
PLoS One; 2015; 10(10):e0139710. PubMed ID: 26436664
[TBL] [Abstract][Full Text] [Related]
12. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.
Nussbaum JM; Schilling S; Cynis H; Silva A; Swanson E; Wangsanut T; Tayler K; Wiltgen B; Hatami A; Rönicke R; Reymann K; Hutter-Paier B; Alexandru A; Jagla W; Graubner S; Glabe CG; Demuth HU; Bloom GS
Nature; 2012 May; 485(7400):651-5. PubMed ID: 22660329
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of water-soluble amyloid beta-peptide in Alzheimer's disease and Down's syndrome brains.
Russo C; Saido TC; DeBusk LM; Tabaton M; Gambetti P; Teller JK
FEBS Lett; 1997 Jun; 409(3):411-6. PubMed ID: 9224700
[TBL] [Abstract][Full Text] [Related]
14. Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanisms.
Hartlage-Rübsamen M; Morawski M; Waniek A; Jäger C; Zeitschel U; Koch B; Cynis H; Schilling S; Schliebs R; Demuth HU; Rossner S
Acta Neuropathol; 2011 Jun; 121(6):705-19. PubMed ID: 21301857
[TBL] [Abstract][Full Text] [Related]
15. Pyroglutamate-Aβ: role in the natural history of Alzheimer's disease.
Gunn AP; Masters CL; Cherny RA
Int J Biochem Cell Biol; 2010 Dec; 42(12):1915-8. PubMed ID: 20833262
[TBL] [Abstract][Full Text] [Related]
16. Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons.
Zhang Y; McLaughlin R; Goodyer C; LeBlanc A
J Cell Biol; 2002 Feb; 156(3):519-29. PubMed ID: 11815632
[TBL] [Abstract][Full Text] [Related]
17. Structural analysis of the pyroglutamate-modified isoform of the Alzheimer's disease-related amyloid-β using NMR spectroscopy.
Sun N; Hartmann R; Lecher J; Stoldt M; Funke SA; Gremer L; Ludwig HH; Demuth HU; Kleinschmidt M; Willbold D
J Pept Sci; 2012 Nov; 18(11):691-5. PubMed ID: 23001756
[TBL] [Abstract][Full Text] [Related]
18. N-Terminal pyroglutamate formation of Aβ38 and Aβ40 enforces oligomer formation and potency to disrupt hippocampal long-term potentiation.
Schlenzig D; Rönicke R; Cynis H; Ludwig HH; Scheel E; Reymann K; Saido T; Hause G; Schilling S; Demuth HU
J Neurochem; 2012 Jun; 121(5):774-84. PubMed ID: 22375951
[TBL] [Abstract][Full Text] [Related]
19. Generation of amyloid beta peptide with pyroglutamate at position 3 in primary cortical neurons.
Shirotani K; Tsubuki S; Lee HJ; Maruyama K; Saido TC
Neurosci Lett; 2002 Jul; 327(1):25-8. PubMed ID: 12098492
[TBL] [Abstract][Full Text] [Related]
20. Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain.
Harigaya Y; Saido TC; Eckman CB; Prada CM; Shoji M; Younkin SG
Biochem Biophys Res Commun; 2000 Sep; 276(2):422-7. PubMed ID: 11027491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
